pharmacy knowledge youtube channel
Open in Telegram
1 130
Subscribers
No data24 hours
No data7 days
-430 days
Posts Archive
1 delhi registration needed for patel nagar near Rajiv chowk
Only West Delhi Candidate or nearby candidate DM me asap or by today
https://youtu.be/lSsCHlZ7NyI?si=3YNszXBba1FzeRy9
13 Post Pharmacist Vacancy at ECHS Polyclinic under Ministry of Defence All India Candidate Eligible
https://youtu.be/uEwn2L8J8BQ?si=Ku8ZRZAKk2NdhqBg
GPAT 2025 Date Announced by NBEMS
Online application date ? EXAM date ? Result date ?
https://youtu.be/vgAzs52XF8g?si=KRD5pOyeqErJPcAj
AIIMS CRE Pharmacist Exam 2025 Memory based Questions with answers .
Check your answer
Must watch full video and share among other
https://youtu.be/8KVOIGoRALg?si=QUicro_Gn7rPyIfX
50 Important Pharma MCQ's by pharmacy knowledge.
VVI MCQ'S for all Government Pharmacist Exam.
Must watch full video and share among others
Join us on other social media ππ»
YouTube :-
https://youtube.com/@pharmacyknowledge?si=F2cIcY5YjJhWjCgl
Telegram :- https://t.me/pharmacyandknowledge
Facebook Page :- https://www.facebook.com/pharmacygyan?mibextid=ZbWKwL
Facebook Group :- https://m.facebook.com/groups/879743609167321/?ref=share&mibextid=NSMWBT
Instagram :- https://www.instagram.com/pharmacyandknowledge?igsh=Z3VyMXh0c3loY3Q1
https://youtu.be/KOag_Xc2tg4?si=zGxroxlN_eMfWNMq
100 MCQ's of Previous year Pharmacist Exam
Must watch full video and share among others . VVI Pharma MCQ for AIIMS, RRB , DSSSB , GPAT , UP NHM , AAMC , ISRO Etc.
Join us on other social media ππ»
YouTube :-
https://youtube.com/@pharmacyknowledge?si=F2cIcY5YjJhWjCgl
Telegram :- https://t.me/pharmacyandknowledge
Facebook Page :- https://www.facebook.com/pharmacygyan?mibextid=ZbWKwL
Facebook Group :- https://m.facebook.com/groups/879743609167321/?ref=share&mibextid=NSMWBT
Instagram :- https://www.instagram.com/pharmacyandknowledge?igsh=Z3VyMXh0c3loY3Q1
Allopurinol is a xanthine oxidase inhibitor primarily used to lower uric acid levels in conditions like gout and hyperuricemia. Its mechanisms of action include:
Xanthine Oxidase Inhibition:
Allopurinol and its active metabolite, oxypurinol, inhibit xanthine oxidase, the enzyme responsible for converting hypoxanthine β xanthine β uric acid.
This leads to reduced uric acid production, decreasing serum and urinary uric acid levels.
Increase in Hypoxanthine and Xanthine Levels:
Hypoxanthine and xanthine are more soluble than uric acid and are more easily excreted in urine.
Reduction of Uric Acid Crystal Formation:
Lower uric acid levels help prevent the formation and deposition of urate crystals in joints and tissues, reducing gout attacks.
Join us on other social media ππ»
YouTube :-
https://youtube.com/@pharmacyknowledge?si=F2cIcY5YjJhWjCgl
Telegram :- https://t.me/pharmacyandknowledge
Facebook Page :- https://www.facebook.com/pharmacygyan?mibextid=ZbWKwL
Facebook Group :- https://m.facebook.com/groups/879743609167321/?ref=share&mibextid=NSMWBT
Instagram :- https://www.instagram.com/pharmacyandknowledge?igsh=Z3VyMXh0c3loY3Q1
Purine Salvage Pathway Modulation:
By increasing hypoxanthine levels, allopurinol promotes hypoxanthine reutilization via the hypoxanthine-guanine phosphoribosyltransferase (HGPRT) pathway, which can reduce purine synthesis and further uric acid production.
Potential Antioxidant Effects:
Xanthine oxidase generates reactive oxygen species (ROS) during uric acid production. Inhibiting the enzyme may reduce oxidative stress, which is relevant in conditions like cardiovascular diseases.
Because of these mechanisms, allopurinol is used in gout, tumor lysis syndrome, and other hyperuricemic conditions. However, it does not treat acute gout attacks and can sometimes trigger them when first initiated due to urate crystal mobilization.
Allopurinol is a xanthine oxidase inhibitor primarily used to lower uric acid levels in conditions like gout and hyperuricemia. Its mechanisms of action include:
Xanthine Oxidase Inhibition:
Allopurinol and its active metabolite, oxypurinol, inhibit xanthine oxidase, the enzyme responsible for converting hypoxanthine β xanthine β uric acid.
This leads to reduced uric acid production, decreasing serum and urinary uric acid levels.
Increase in Hypoxanthine and Xanthine Levels:
Hypoxanthine and xanthine are more soluble than uric acid and are more easily excreted in urine.
Reduction of Uric Acid Crystal Formation:
Lower uric acid levels help prevent the formation and deposition of urate crystals in joints and tissues, reducing gout attacks.
Join us on other social media ππ»
YouTube :-
https://youtube.com/@pharmacyknowledge?si=F2cIcY5YjJhWjCgl
Telegram :- https://t.me/pharmacyandknowledge
Facebook Page :- https://www.facebook.com/pharmacygyan?mibextid=ZbWKwL
Facebook Group :- https://m.facebook.com/groups/879743609167321/?ref=share&mibextid=NSMWBT
Instagram :- https://www.instagram.com/pharmacyandknowledge?igsh=Z3VyMXh0c3loY3Q1
Purine Salvage Pathway Modulation:
By increasing hypoxanthine levels, allopurinol promotes hypoxanthine reutilization via the hypoxanthine-guanine phosphoribosyltransferase (HGPRT) pathway, which can reduce purine synthesis and further uric acid production.
Potential Antioxidant Effects:
Xanthine oxidase generates reactive oxygen species (ROS) during uric acid production. Inhibiting the enzyme may reduce oxidative stress, which is relevant in conditions like cardiovascular diseases.
Because of these mechanisms, allopurinol is used in gout, tumor lysis syndrome, and other hyperuricemic conditions. However, it does not treat acute gout attacks and can sometimes trigger them when first initiated due to urate crystal mobilization.
Pharmacognosy:
1. Which of the following is an alkaloid?
a) Starch
b) Morphine
c) Cellulose
d) Pectin
Answer: b) Morphine
2. Glycosides are hydrolyzed by which enzyme?
a) Lipase
b) Amylase
c) Glycosidase
d) Protease
Answer: c) Glycosidase
3. Digitalis is used in the treatment of:
a) Hypertension
b) Cardiac disorders
c) Diabetes
d) Asthma
Answer: b) Cardiac disorders
4. Which of the following is a source of atropine?
a) Ephedra
b) Belladonna
c) Rauwolfia
d) Cinchona
Answer: b) Belladonna
Join us on other social media ππ»
YouTube :-
https://youtube.com/@pharmacyknowledge?si=F2cIcY5YjJhWjCgl
Telegram :- https://t.me/pharmacyandknowledge
Facebook Page :- https://www.facebook.com/pharmacygyan?mibextid=ZbWKwL
Facebook Group :- https://m.facebook.com/groups/879743609167321/?ref=share&mibextid=NSMWBT
Instagram :- https://www.instagram.com/pharmacyandknowledge?igsh=Z3VyMXh0c3loY3Q1
5. The main chemical constituent of Clove is:
a) Eugenol
b) Quinine
c) Atropine
d) Reserpine
Answer: a) Eugenol
6. The biological source of Quinine is:
a) Cinchona bark
b) Clove
c) Ginger
d) Liquorice
Answer: a) Cinchona bark
7. Sennosides are obtained from:
a) Aloe
b) Senna
c) Belladonna
d) Ipecac
Answer: b) Senna
8. Which of the following drugs is a cardiac glycoside?
a) Digitalis
b) Atropine
c) Ephedrine
d) Quinine
Answer: a) Digitalis
9. Which plant family does Rauwolfia belong to?
a) Liliaceae
b) Apocynaceae
c) Fabaceae
d) Solanaceae
Answer: b) Apocynaceae
10. Tannins are best extracted using:
a) Alcohol
b) Water
c) Chloroform
d) Ether
Answer: b) Water
πππ£ππππ’π¦π£π’π₯ππ‘ πππ‘ππ₯ππ§ππ’π‘π¦: π ππ’π π£π₯ππππ‘π¦ππ©π ππ¨πππ
1. First Generation
Coverage:
π£ Gram-positive: Excellent activity, especially against Staphylococcus aureus (excluding MRSA) and Streptococcus pyogenes.
π£ Gram-negative: Limited activity, primarily effective against Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
Examples:
π£ Cefazolin (IV)
π£ Cephalexin (oral)
π£ Cefadroxil (oral)
Uses:
π£ Surgical prophylaxis (e.g., cefazolin)
π£ Skin and soft tissue infections
π£ UTIs caused by susceptible organisms
2. Second Generation
Coverage:
π Gram-positive: Similar to the first generation but slightly less effective.
π Gram-negative: Expanded activity, covering Haemophilus influenzae, Enterobacter species, Neisseria gonorrhoeae, Escherichia coli, and Proteus mirabilis.
π Some agents (e.g., cephamycins like cefotetan, cefoxitin) have anaerobic coverage.
Examples:
π Cefuroxime (IV/oral)
π Cefoxitin (IV) β a cephamycin
π Cefotetan (IV) β a cephamycin
π Cefaclor (oral)
Uses:
π Respiratory tract infections (e.g., sinusitis, otitis media, bronchitis)
π Surgical prophylaxis for abdominal and pelvic surgeries (e.g., cefoxitin, cefotetan)
π Mixed anaerobic infections (cephamycins)
3. Third Generation
Coverage:
π΄ Gram-positive: Good activity but less effective against Staphylococcus aureus than earlier generations.
π΄ Gram-negative: Broad-spectrum coverage, including Enterobacteriaceae, Haemophilus influenzae, and Neisseria.
π΄ Some agents (e.g., ceftazidime) cover Pseudomonas aeruginosa.
π΄ Generally poor anaerobic coverage.
Examples:
π΄ Ceftriaxone (IV)
π΄ Cefotaxime (IV)
π΄ Ceftazidime (IV) β covers Pseudomonas
π΄ Cefdinir (oral)
π΄ Cefixime (oral)
Uses:
π΄ Community-acquired pneumonia
π΄ Meningitis (ceftriaxone, cefotaxime)
π΄ Gonorrhea (ceftriaxone)
π΄ Severe UTIs and pyelonephriti
π΄ Hospital-acquired infections (Pseudomonas coverage with ceftazidime)
Join us on other social media ππ»
YouTube :-
https://youtube.com/@pharmacyknowledge?si=F2cIcY5YjJhWjCgl
Telegram :- https://t.me/pharmacyandknowledge
Facebook Page :- https://www.facebook.com/pharmacygyan?mibextid=ZbWKwL
Facebook Group :- https://m.facebook.com/groups/879743609167321/?ref=share&mibextid=NSMWBT
Instagram :- https://www.instagram.com/pharmacyandknowledge?igsh=Z3VyMXh0c3loY3Q1
4. Fourth Generation
Coverage:
π΅ Gram-positive: Good coverage, including Streptococcus pneumoniae.
π΅ Gram-negative: Very broad, including Pseudomonas aeruginosa, Enterobacter species, and other resistant gram-negative organisms.
π΅ No anaerobic coverage.
Example:
π΅ Cefepime (IV)
Uses:
π΅ Hospital-acquired pneumonia
π΅ Febrile neutropenia
π΅ Complicated UTIs
π΅ Infections caused by multidrug-resistant organisms (Pseudomonas focus)
5. Fifth Generation
Coverage:
π€ Gram-positive: Excellent activity, including MRSA and penicillin-resistant Streptococcus pneumoniae.
π€ Gram-negative: Broad-spectrum but no Pseudomonas coverage.
π€ Minimal anaerobic coverage.
Example:
π€ Ceftaroline (IV)
Uses:
π€ Skin and soft tissue infections (e.g., caused by MRSA)
π€ Community-acquired pneumonia
